Literature DB >> 3065843

Surgical treatment of osteoarthritis of the shoulder.

A D Boyd1, T S Thornhill.   

Abstract

Shoulder dysfunction is unusual in osteoarthritis and usually responds to conservative treatment. The primary indication for surgery is pain unresponsive to medical management. The procedure of choice for degenerative changes in the glenohumeral joint is hemiarthroplasty or total shoulder replacement depending on the condition of the glenoid. Shoulder fusion is rarely necessary for osteoarthritis and is recommended for chronic infection, flail shoulder, and failed total shoulder replacement not amenable to revision. Joint resection is reserved for infected joints with massive bone loss. The results of shoulder arthroplasty are good to excellent in 86 to 94 per cent of all patients. The results of shoulder arthrodesis are less predictable, but are usually satisfactory in approximately 75 per cent of patients with 10-year follow-up. The treatment of AC and SC joint arthritis is conservative with rest, local heat, and medication. Pain unresponsive to this regimen is an indication for resection of the joint. Good results with this procedure directly correlate with pain relief on injection of the joint with local anesthetic.

Entities:  

Mesh:

Year:  1988        PMID: 3065843

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  3 in total

1.  Septic Arthritis of the Shoulder with Proximal Humerus Osteomyelitis, Treated by Ilizarov Shoulder Arthrodesis.

Authors:  John Kendall; Martin McNally
Journal:  J Bone Jt Infect       Date:  2017-01-19

2.  Evaluation of the Results from Partial Arthroplasty for Treating Shoulder Osteoarthrosis.

Authors:  Alberto Naoki Miyazaki; Marcelo Fregoneze; Pedro Doneux Santos; Luciana Andrade da Silva; Guilherme do Val Sella; Rodrigo Zampieri; Eduardo Régis de Alencar Bona Miranda; Sergio Luiz Checchia
Journal:  Rev Bras Ortop       Date:  2013-06-20

Review 3.  [Shoulder arthroplasty in rheumatoid arthritis].

Authors:  A Hedtmann; A Werner
Journal:  Orthopade       Date:  2007-11       Impact factor: 1.004

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.